Unknown

Dataset Information

0

T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS.


ABSTRACT: T-cell activation is a major pathway driving HIV disease progression. Little is known regarding the impact of T-cell activation on HIV-associated atherosclerosis and cardiovascular disease, a common comorbidity in HIV infection. We hypothesized that T-cell activation will predict vascular stiffness, a measure of subclinical atherosclerosis.Linear regression models evaluated the covariate-adjusted association of T-cell activation with vascular stiffness.CD38 and HLA-DR expression on CD4? and CD8? T cells was assessed by flow cytometry among 59 HIV-negative and 376 HIV-infected (185 hepatitis C coinfected) women in the Women's Interagency HIV Study. T-cell activation was defined by CD8?CD38?DR+ and CD4?CD3?8DR+. Multiple activation assessments over 6.5 years were averaged. In 140 women, T-cell activation was measured before and after highly active antiretroviral therapy (HAART) initiation. Carotid artery ultrasounds were completed a median of 6.5 years after last measurement of T-cell activation and carotid artery stiffness including distensibility and elasticity were calculated.Percentages of CD4? and CD8? T-cell activation were significantly higher in HIV- infected compared with HIV-negative women. Among HIV-negative women, T-cell activation was not associated with carotid artery stiffness. Among HIV-infected women, higher CD4? T-cell activation levels significantly predicted increased arterial stiffness independent of CD4? cell count and HIV RNA. The association was stronger among HIV/hepatitis C-coinfected women compared with HIV-monoinfected women; however, the difference was not statistically significant (P for interaction >0.05). Pre- and post-HAART levels of CD4? T-cell activation significantly predicted carotid artery stiffness.Persistent T-cell activation, even after HAART initiation, can contribute to structural and/or functional vascular damage accelerating atherogenesis in HIV infection. These results need to be confirmed in a longitudinal prospective study.

SUBMITTER: Karim R 

PROVIDER: S-EPMC4197806 | biostudies-other | 2014 Nov

REPOSITORIES: biostudies-other

altmetric image

Publications

T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS.

Karim Roksana R   Mack Wendy J WJ   Kono Naoko N   Tien Phyllis C PC   Anastos Kathryn K   Lazar Jason J   Young Mary M   Desai Seema S   Golub Elizabeth T ET   Kaplan Robert C RC   Hodis Howard N HN   Kovacs Andrea A  

Journal of acquired immune deficiency syndromes (1999) 20141101 3


<h4>Objective</h4>T-cell activation is a major pathway driving HIV disease progression. Little is known regarding the impact of T-cell activation on HIV-associated atherosclerosis and cardiovascular disease, a common comorbidity in HIV infection. We hypothesized that T-cell activation will predict vascular stiffness, a measure of subclinical atherosclerosis.<h4>Design</h4>Linear regression models evaluated the covariate-adjusted association of T-cell activation with vascular stiffness.<h4>Method  ...[more]

Similar Datasets

| S-EPMC5145748 | biostudies-other
| S-EPMC9851463 | biostudies-literature
| S-EPMC5767749 | biostudies-literature
| S-EPMC3948580 | biostudies-literature
| S-EPMC4462651 | biostudies-literature
| S-EPMC5997527 | biostudies-literature
| S-EPMC9331379 | biostudies-literature
| S-EPMC3888489 | biostudies-literature
| S-EPMC10325775 | biostudies-literature
| S-EPMC4304990 | biostudies-literature